Open Science is gaining ground in all research fields, including health economics and outcomes research (HEOR). However, teaching Open Science is still in its infancy. This paper describes the design, implementation and evaluation of a teaching …
This series of lecture slides were used during the "Advanced Simulation for Health Economic Analysis" course at the University of Twente, which took place in February - May 2023.
The following Open Science topics were introduced to the course …
In the past decade, behavioral science has seen the introduction of beneficial reforms to reduce false positive results. Serving as the motivational backdrop for the present research, we wondered whether these reforms might have unintended negative …
LCIRT was established in 2001 to pioneer LD research, discover innovative strategies and practices, and improve teaching and learning outcomes for students with learning disabilities (like dyslexia), ADHD, and autism spectrum disorder (ASD), and …
Last Contact is a game is a game that is intended to inform people about the open science movement. In the game players encounter common problems of current scientific practice in form of a parody science fiction scenario. The problems that players …
Academic institutions have made significant investments to support public access to research data requirements, yet little to no data about these services, infrastructure, and costs currently exist or are widely shared. For public access to research …
Science journalists are uniquely positioned to increase the societal impact of open science by contextualizing and communicating research findings in ways that highlight their relevance and implications for non-specialist audiences. Through …
Patient advocacy organizations (PAOs) advance patient interests through promotion of disease awareness, engagement with policymakers, and partnership with medical product manufacturers in research and development.1 However, there are concerns that, …
In the UK, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medicines”. The …